Receptor, IGF Type 1
- Name
- Receptor, IGF Type 1
- Accession Number
- DBCAT001742
- Description
Not Available
- Drugs
Drug Drug Description Cixutumumab Cixutumumab has been used in trials studying the treatment of Lung Cancer, Malignant Neoplasm, Leukemia, Mast-Cell, Non-Small-Cell Lung Carcinoma, and Adenocarcinoma of the Prostate. Cixutumumab is a highly specific recombinant... - Drugs & Drug Targets
Drug Target Type Cixutumumab Insulin-like growth factor 1 receptor target